equitysell

ISRG

ISRG — thematic research focused on surgical robotics and the broader robotics narrative. We highlight a high-conviction view that advances in autonomy validate the humanoid and general-purpose robotics story, while noting timing and regulatory hurdles for revenue realization.

Opportunity
34 / 100
Current score
-0.56
Thesis calls
2
Active ticker theses
2

Recent proof-backed thesis calls

No published buy/sell calls or analyst recommendations are on file for this ticker.

arXiv cs.LGrsswrong

Scientific paper proposes a unified benchmark (60 healthy subjects, 3 cadences) to predict hip muscle forces and joint moments directly from gait kinematics using sequence models; Transformer performed best and showed only moderate zero-shot generalization to a small external pathological cohort (9 ONFH patients). Investable implication is not the specific model, but acceleration/automation of gait analytics and biomechanics-derived metrics from cheaper kinematics inputs (wearables/markerless ca

Mentioned: Jun 1, 2026, 12:00 AM EDTConviction: 26 / 100Return: -7.69%
Source: Gait2Hip-60: A Unified Deep Learning Benchmark for Predicting Hip Muscle Forces and Joint Moments from Multi-Cadence Gait Kinematics

Post reports ISRG beat Q2 revenue expectations ($2.89B) but shares fell sharply (~-13%) on concerns about slowing U.S. procedure growth (12% YoY) plus analyst caution. Actionable primarily as an earnings/post-earnings momentum and expectations-reset signal for ISRG; limited broader read-through without more detail.

Mentioned: Jul 17, 2026, 3:04 PM EDTConviction: 56 / 100Observed price: $348.48 on 2026-07-17Return: 5.45%
Source: Seeking Alpha @SeekingAlpha 29m Intuitive Surgical $ISRG shares dipped despite beating Q2 revenue expectations, as do...

Current stance

No active recommendation is published for ISRG at this time.

Recommendationsell
Authors2
Active ticker theses2
Latest pricen/a
Why now
  • sell via ISRG post-earnings downside continuation / expectations reset from https://x.com/seekingalpha (confidence 0.56)
  • hold via Humanoid and general-purpose robotics narrative receives validation, but revenue timing remains uncertain. from https://www.youtube.com/@ycombinator (confidence 0.38)

Unlock full asset monitoring

Follow this page for updates on thematic research and any future recommendations related to ISRG and the robotics narrative.

ISRG | AI Frontrunner